Analysis of Interleukin-27 (EBI3/p28) Expression in Epstein-Barr Virus- and Human T-Cell Leukemia Virus Type 1-Associated Lymphomas
- 1 April 2005
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 166 (4) , 1217-1228
- https://doi.org/10.1016/s0002-9440(10)62340-1
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-κB activation in anaplastic large cell lymphomaCancer Cell, 2004
- Role of NF-κB in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected CellsJournal of Virology, 2004
- Potent Antitumor Activity of Interleukin-27Cancer Research, 2004
- B cells under influence: transformation of B cells by Epstein–Barr virusNature Reviews Immunology, 2003
- Bay 11-7082 inhibits transcription factor NF-kappa B and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cellsBlood, 2002
- Cytokine signaling and Epstein-Barr virus-mediated cell transformationCytokine & Growth Factor Reviews, 2001
- Novel NEMO/IκB Kinase and NF-κB Target Genes at the Pre-B to Immature B Cell TransitionJournal of Biological Chemistry, 2001
- Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-κBOncogene, 1999
- NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implicationsExperimental Hematology, 1999
- HTLV-I messenger RNA is expressedin vivo in adult T-cell leukemia/lymphoma patients: Anin situ hybridization studyInternational Journal of Cancer, 1994